Loading stock data…
Quest Diagnostics Incorporated (DGX)
$227.86-0.04 (-0.02%)
Market ClosedLast close Jul 24
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Quest Diagnostics Incorporated in the Healthcare sector is trading at $227.86 with a market capitalization of $21.5B. Wall Street consensus targets $239.38 (16 analysts), implying a +5.1% move over the next 12 months. The stock is currently near its 52-week high of $237.78, remaining 19.1% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +5.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.90B↑ | $2.81B↓ | $2.82B↑ | $2.76B↑ | $2.65B |
| Gross Profit | $942.00M↑ | $910.00M↓ | $949.00M↑ | $943.00M↑ | $863.00M |
| Operating Income | $404.00M↑ | $386.00M | $386.00M↓ | $438.00M↑ | $351.00M |
| Net Income | $252.00M↑ | $245.00M | $245.00M↓ | $282.00M↑ | $220.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$21.50B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.44
Beta
Defensive asset. Lower volatility than the S&P 500.
0.59
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.43%
ROE
Average efficiency. Growth may require heavy reinvestment.
13.90%
Volume
Today's trading volume
1.33M
Recent News
Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great Choice
Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics Incorporated Q2 2026 Earnings Call Summary
Moby summary of Quest Diagnostics Incorporated's Q2 2026 earnings call
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
Quest Diagnostics Inc (DGX) reports robust financial performance with a 10% revenue increase, while navigating operational headwinds and strategic investments.
Quest Diagnostics Surges After Hims- And Oura-Tied Beat
Quest Diagnostics put up a definitive beat Thursday, driven by solid demand across its consumer division, leading the stock to surge.